HIGHLIGHTS
- who: Marion Barrieu et al. from the Université Clermont Auvergne, CHU Clermont Ferrand, Clermont Auvergne INP, CNRS, ICCF have published the research work: Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases, in the Journal: Pharmaceutics 2022, 118 of /2022/
- what: The aim of this study was to evaluate the physicochemical stability of a preservative-free tacrolimus formulation (0.2 and 1 mg/mL) at three storage temperatures (5 ◦ C 25 ◦ C and 35 ◦ C) for up to nine months in a multidose eyedropper.
- how: The accuracy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.